STAT

Heart group warns of cardiovascular risks after treatment for breast cancer

The American Heart Association warns that breast cancer survivors treated with common chemotherapies are at increased risk for heart disease.
Source: Larry Ostby/National Cancer Institute

Cardiologists are not telling women with breast cancer to decline treatment — far from it. But in its first-ever statement on the most common female cancer, the American Heart Association warned on Thursday that breast cancer survivors, especially those treated with common chemotherapies, are at increased risk for heart failure and other cardiovascular diseases. And it called on cancer doctors to weigh the benefits of those treatments against the heart risks they pose.

It has been known for years that some breast cancer drugs (including some also used

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks